Wegovy is the brand name for semaglutide 2.4 mg, a prescription medicine licensed in the UK for weight management in adults with obesity or those who are overweight with weight-related health conditions
However, others have reported the opposite effect, where edible cannabis appears to increase their appetite, potentially counteracting the intended effects of the GLP-1 medication
* At-home options are also available for an additional fee
At the same time, GLP-1 can also enhance the proliferation and differentiation of cells and protect them from apoptosis [21]
However, fasting plasma triglycerides were significantly reduced in Dpp4 / mice (Figure 3H)
Furthermore, these mechanisms may underlie the use of the diabetes drug GLP-1 RA to treat AD and PD